Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
US population-based analysis of smoldering myeloma finds 76% 5-year OS (2016-2019) vs. 50.5% for symptomatic myeloma; lowest in pts ≥80 years and in Hispanics, highest in Black vs. White and other races, highest in East.”
Title: Smoldering multiple myeloma in the United States: A population-based analysis
Authors: Shi-Yi Wang, Rong Wang, Martin Schoen, John H Huber, Eric Feuer, Jennifer Ruhl, Natalia Neparidze, Xiaomei Ma, Amy J Davidoff, Su-Hsin Chang
You can read the Full Article in Blood Advances.
You can find more posts featuring Robert Orlowski on OncoDaily.
